Atlas Trials

Esmolol Effects on Heart and Inflammation in Septic Shock

Clinical trial NCT02068287 · UNKNOWN

Trial details

NCT number
NCT02068287
Sponsor
Central Hospital, Nancy, France
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Septic Shock
Start date
2013-12-01
Primary completion
2016-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.